Surefire Medical, Inc. today announced that Mats Wahlström is joining the company’s Board of Directors and will serve as chairman

Surefire to Collaborate with Roger Williams Medical Center and University of Colorado School of Medicine

German Classification Code issued, allows for tracking and measuring use of Surefire devices

Surefire Precision Infusion System was associated with a 68 percent complete tumor response and 92 percent objective tumor response